Research: Efficacy of Solifenacin for Overactive Bladder Symptoms, Symptom Bother, and Health-Related Quality of Life in Patients by Duration of Self-Reported Symptoms: A Secondary Analysis of the VIBRANT Study

Research: Efficacy of Solifenacin for Overactive Bladder Symptoms, Symptom Bother, and Health-Related Quality of Life in Patients by Duration of Self-Reported Symptoms: A Secondary Analysis of the VIBRANT Study


Identification: unj_jf12_04
Issue: January-February 2012
Volume: Volume 32 Number 1

Standard: $15.00

Description

Acknowledgments and Author Contributions: The VIBRANT Study was undertaken with a research grant from Astellas Pharma U.S.; Inc. and GlaxoSmithKline. Editorial support; including writing assistance; was provided by Linda A. Goldstein; PhD; a medical writer at Envision Pharma; Inc.; and was funded by Astellas Pharma Global Development; Inc. and GlaxoSmithKline.

Speaker(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content